GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Cydsa SAB de CV (OTCPK:CDSAF) » Definitions » EBIT

CydsaB de CV (CydsaB de CV) EBIT : $185.3 Mil (TTM As of Mar. 2024)


View and export this data going back to . Start your Free Trial

What is CydsaB de CV EBIT?

CydsaB de CV's earnings before interest and taxes (EBIT) for the three months ended in Mar. 2024 was $33.9 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Mar. 2024 was $185.3 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. CydsaB de CV's annualized ROC % for the quarter that ended in Mar. 2024 was 7.55%. CydsaB de CV's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2024 was 12.40%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. CydsaB de CV's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2024 was 15.12%.


CydsaB de CV EBIT Historical Data

The historical data trend for CydsaB de CV's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CydsaB de CV EBIT Chart

CydsaB de CV Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only 115.38 93.05 89.40 135.26 208.96

CydsaB de CV Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 54.66 58.16 42.62 50.63 33.91

Competitive Comparison of CydsaB de CV's EBIT

For the Chemicals subindustry, CydsaB de CV's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CydsaB de CV's EV-to-EBIT Distribution in the Chemicals Industry

For the Chemicals industry and Basic Materials sector, CydsaB de CV's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where CydsaB de CV's EV-to-EBIT falls into.



CydsaB de CV EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $185.3 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


CydsaB de CV  (OTCPK:CDSAF) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

CydsaB de CV's annualized ROC % for the quarter that ended in Mar. 2024 is calculated as:

ROC % (Q: Mar. 2024 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Dec. 2023 ) + Invested Capital (Q: Mar. 2024 ))/ count )
=153.4 * ( 1 - 32.53% )/( (1382.034 + 1357.866)/ 2 )
=103.49898/1369.95
=7.55 %

where

Invested Capital(Q: Dec. 2023 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=1680.192 - 204.074 - ( 94.084 - max(0, 282.251 - 428.944+94.084))
=1382.034

Invested Capital(Q: Mar. 2024 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=1713.886 - 229.938 - ( 126.082 - max(0, 323.35 - 458.494+126.082))
=1357.866

Note: The Operating Income data used here is four times the quarterly (Mar. 2024) data.

2. Joel Greenblatt's definition of Return on Capital:

CydsaB de CV's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2024 is calculated as:

ROC (Joel Greenblatt) %(Q: Mar. 2024 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Dec. 2023  Q: Mar. 2024
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=135.632/( ( (1020.899 + max(87.544, 0)) + (1023.131 + max(56.589, 0)) )/ 2 )
=135.632/( ( 1108.443 + 1079.72 )/ 2 )
=135.632/1094.0815
=12.40 %

where Working Capital is:

Working Capital(Q: Dec. 2023 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(156.354 + 81.3 + 97.206) - (204.074 + 0 + 43.242)
=87.544

Working Capital(Q: Mar. 2024 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(137.056 + 81.496 + 75.715) - (229.938 + 0 + 7.74)
=56.589

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Mar. 2024) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

CydsaB de CV's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Mar. 2024 )
=185.309/1225.767
=15.12 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


CydsaB de CV EBIT Related Terms

Thank you for viewing the detailed overview of CydsaB de CV's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


CydsaB de CV (CydsaB de CV) Business Description

Traded in Other Exchanges
Address
Av. Ricardo Margain Zozaya No. 335, Tower 2, Floor 6, Col. Valle del Campestre, Garza Garcia, NL, MEX, 66265
Cydsa SAB de CV is engaged in production and sales of plastic pipes and fittings and irrigation systems, refrigerant gas, acrylic yarns, polyvinyl chloride resin, chlorine-caustic soda, and salt. The operating segments of the company are Chemical Products and Specialties, Refrigerant Gases and Energy Processing and Logistics. It generates maximum revenue from the Chemical Products and Specialties segment. Geographically, it derives a majority of revenue from Mexico and also has a presence in the United States and Canada; Central and South America and Europe.